CleopatraRX has filed a notice of an exempt offering of securities to raise $2,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, CleopatraRX is raising $2,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Kevin Murray played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About CleopatraRX
Cleopatra RX provides women who have cognitive difficulties from aging with cutting-edge treatments and supplements to eliminate brain fog and give them a clearer mind. Developed by Neuroscientist and World-Renowned Expert in Brain Health, Rhonda R. Voskuhl, M.D. Rhonda Voskuhl, M.D. is a research scientist and professor of neurology at UCLA. Director of the Brain Research Institute (BRI). Her discovery of estrogen loss and its effect on cognition, was identified during her extensive research on cognitive function in individuals with multiple sclerosis.
To learn more about CleopatraRX, visit http://cleopatrarx.com/
Contact:
Kevin Murray, Chief Financial Officer
918-906-3000
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.